Caladan Therapeutics
NY - BrooklynBiotechnology
Focus: Caladan Therapeutics is a Brooklyn-based biotechnology company focused on bioreactor system development for the ophthalmology space. The company operates at an early stage with limited public disclosure of scale.
Profile data last refreshed 42m ago · AI intelligence enriched 2w ago
Open Jobs
6+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Caladan Therapeutics?
AI assessmentHigh technical potential in a niche therapeutic area, but significant stage and visibility risk; suitable only for early-stage risk-tolerant candidates with platform-science interest.
Why Work Here
- Early-stage biotech opportunity in ophthalmology, a high-value specialty with unmet needs and strong exit precedent.
- Specialized focus on bioreactor systems offers deep technical expertise in a differentiated manufacturing platform.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (6)
Interview Prep Quick Facts
Help build intelligence for Caladan Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.